Insufficient scRNA-seq data for expression of LEP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 87% | 14846.76 | 399 / 459 | 42% | 5.51 | 470 / 1118 |
adipose | 96% | 26147.93 | 1160 / 1204 | 0% | 0 | 0 / 0 |
skin | 39% | 1092.81 | 706 / 1809 | 7% | 0.28 | 34 / 472 |
bladder | 19% | 144.71 | 4 / 21 | 11% | 0.66 | 56 / 504 |
pancreas | 8% | 39.34 | 27 / 328 | 22% | 2.27 | 39 / 178 |
blood vessel | 26% | 494.77 | 343 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 22% | 2.21 | 10 / 45 |
peripheral blood | 21% | 149.68 | 193 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.60 | 6 / 29 |
stomach | 8% | 55.61 | 27 / 359 | 8% | 0.44 | 23 / 286 |
intestine | 11% | 150.19 | 105 / 966 | 4% | 0.51 | 19 / 527 |
lung | 1% | 1.75 | 4 / 578 | 12% | 0.89 | 142 / 1155 |
adrenal gland | 8% | 63.68 | 21 / 258 | 3% | 0.06 | 8 / 230 |
uterus | 0% | 0 | 0 / 170 | 11% | 1.05 | 51 / 459 |
esophagus | 3% | 49.44 | 47 / 1445 | 7% | 0.25 | 13 / 183 |
heart | 8% | 68.91 | 71 / 861 | 0% | 0 | 0 / 0 |
kidney | 1% | 49.99 | 1 / 89 | 6% | 0.23 | 56 / 901 |
muscle | 7% | 40.49 | 58 / 803 | 0% | 0 | 0 / 0 |
spleen | 6% | 17.10 | 15 / 241 | 0% | 0 | 0 / 0 |
thymus | 4% | 32.78 | 23 / 653 | 3% | 0.07 | 16 / 605 |
ovary | 1% | 4.63 | 2 / 180 | 4% | 0.15 | 17 / 430 |
prostate | 1% | 5.28 | 2 / 245 | 1% | 0.01 | 3 / 502 |
liver | 0% | 0 | 0 / 226 | 1% | 0.16 | 4 / 406 |
brain | 0% | 0.10 | 1 / 2642 | 0% | 0.01 | 3 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097009 | Biological process | energy homeostasis |
GO_0050796 | Biological process | regulation of insulin secretion |
GO_0035360 | Biological process | positive regulation of peroxisome proliferator activated receptor signaling pathway |
GO_0050999 | Biological process | regulation of nitric-oxide synthase activity |
GO_0043270 | Biological process | positive regulation of monoatomic ion transport |
GO_0014823 | Biological process | response to activity |
GO_0002021 | Biological process | response to dietary excess |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_1900015 | Biological process | regulation of cytokine production involved in inflammatory response |
GO_2000379 | Biological process | positive regulation of reactive oxygen species metabolic process |
GO_0001666 | Biological process | response to hypoxia |
GO_0042755 | Biological process | eating behavior |
GO_0006909 | Biological process | phagocytosis |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0030073 | Biological process | insulin secretion |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0042445 | Biological process | hormone metabolic process |
GO_0032008 | Biological process | positive regulation of TOR signaling |
GO_0006006 | Biological process | glucose metabolic process |
GO_0001936 | Biological process | regulation of endothelial cell proliferation |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0033686 | Biological process | positive regulation of luteinizing hormone secretion |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0001525 | Biological process | angiogenesis |
GO_0035904 | Biological process | aorta development |
GO_0030300 | Biological process | regulation of intestinal cholesterol absorption |
GO_0046850 | Biological process | regulation of bone remodeling |
GO_0090335 | Biological process | regulation of brown fat cell differentiation |
GO_0008217 | Biological process | regulation of blood pressure |
GO_0042307 | Biological process | positive regulation of protein import into nucleus |
GO_0003300 | Biological process | cardiac muscle hypertrophy |
GO_0007565 | Biological process | female pregnancy |
GO_1900745 | Biological process | positive regulation of p38MAPK cascade |
GO_0033197 | Biological process | response to vitamin E |
GO_0045765 | Biological process | regulation of angiogenesis |
GO_0060587 | Biological process | regulation of lipoprotein lipid oxidation |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0021954 | Biological process | central nervous system neuron development |
GO_0050901 | Biological process | leukocyte tethering or rolling |
GO_0045906 | Biological process | negative regulation of vasoconstriction |
GO_0046881 | Biological process | positive regulation of follicle-stimulating hormone secretion |
GO_0006629 | Biological process | lipid metabolic process |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_1990051 | Biological process | activation of protein kinase C activity |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0032099 | Biological process | negative regulation of appetite |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0032355 | Biological process | response to estradiol |
GO_0038108 | Biological process | negative regulation of appetite by leptin-mediated signaling pathway |
GO_0008206 | Biological process | bile acid metabolic process |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0001542 | Biological process | ovulation from ovarian follicle |
GO_0071298 | Biological process | cellular response to L-ascorbic acid |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0006114 | Biological process | glycerol biosynthetic process |
GO_0045471 | Biological process | response to ethanol |
GO_0042269 | Biological process | regulation of natural killer cell mediated cytotoxicity |
GO_0006111 | Biological process | regulation of gluconeogenesis |
GO_0070093 | Biological process | negative regulation of glucagon secretion |
GO_0050810 | Biological process | regulation of steroid biosynthetic process |
GO_0030217 | Biological process | T cell differentiation |
GO_0044320 | Biological process | cellular response to leptin stimulus |
GO_0033210 | Biological process | leptin-mediated signaling pathway |
GO_0050892 | Biological process | intestinal absorption |
GO_0019953 | Biological process | sexual reproduction |
GO_0046628 | Biological process | positive regulation of insulin receptor signaling pathway |
GO_0060612 | Biological process | adipose tissue development |
GO_0006635 | Biological process | fatty acid beta-oxidation |
GO_0051541 | Biological process | elastin metabolic process |
GO_0010888 | Biological process | negative regulation of lipid storage |
GO_2000491 | Biological process | positive regulation of hepatic stellate cell activation |
GO_0046427 | Biological process | positive regulation of receptor signaling pathway via JAK-STAT |
GO_0032814 | Biological process | regulation of natural killer cell activation |
GO_1904651 | Biological process | positive regulation of fat cell apoptotic process |
GO_0032310 | Biological process | prostaglandin secretion |
GO_0007260 | Biological process | tyrosine phosphorylation of STAT protein |
GO_0008340 | Biological process | determination of adult lifespan |
GO_2000486 | Biological process | negative regulation of glutamine transport |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0008343 | Biological process | adult feeding behavior |
GO_0032735 | Biological process | positive regulation of interleukin-12 production |
GO_0048639 | Biological process | positive regulation of developmental growth |
GO_0032868 | Biological process | response to insulin |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0001890 | Biological process | placenta development |
GO_0007623 | Biological process | circadian rhythm |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0098868 | Biological process | bone growth |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0032817 | Biological process | regulation of natural killer cell proliferation |
GO_0035630 | Biological process | bone mineralization involved in bone maturation |
GO_0006112 | Biological process | energy reserve metabolic process |
GO_0061037 | Biological process | negative regulation of cartilage development |
GO_0042593 | Biological process | glucose homeostasis |
GO_0046325 | Biological process | negative regulation of glucose import |
GO_0005576 | Cellular component | extracellular region |
GO_0005615 | Cellular component | extracellular space |
GO_0005829 | Cellular component | cytosol |
GO_1990460 | Molecular function | leptin receptor binding |
GO_0005179 | Molecular function | hormone activity |
GO_0005515 | Molecular function | protein binding |
GO_0003677 | Molecular function | DNA binding |
GO_0051428 | Molecular function | peptide hormone receptor binding |
Gene name | LEP |
Protein name | Leptin (Obese protein) (Obesity factor) Leptin (Obesity factor) |
Synonyms | OBS OB hCG_33000 tcag7.84 |
Description | FUNCTION: Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways. In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, increases basal metabolism, influences reproductive function, regulates pancreatic beta-cell function and insulin secretion, is pro-angiogenic for endothelial cell and affects innate and adaptive immunity. In the arcuate nucleus of the hypothalamus, activates by depolarization POMC neurons inducing FOS and SOCS3 expression to release anorexigenic peptides and inhibits by hyperpolarization NPY neurons inducing SOCS3 with a consequent reduction on release of orexigenic peptides. In addition to its known satiety inducing effect, has a modulatory role in nutrient absorption. In the intestine, reduces glucose absorption by enterocytes by activating PKC and leading to a sequential activation of p38, PI3K and ERK signaling pathways which exerts an inhibitory effect on glucose absorption. Acts as a growth factor on certain tissues, through the activation of different signaling pathways increases expression of genes involved in cell cycle regulation such as CCND1, via JAK2-STAT3 pathway, or VEGFA, via MAPK1/3 and PI3K-AKT1 pathways. May also play an apoptotic role via JAK2-STAT3 pathway and up-regulation of BIRC5 expression. Pro-angiogenic, has mitogenic activity on vascular endothelial cells and plays a role in matrix remodeling by regulating the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). In innate immunity, modulates the activity and function of neutrophils by increasing chemotaxis and the secretion of oxygen radicals. Increases phagocytosis by macrophages and enhances secretion of pro-inflammatory mediators. Increases cytotoxic ability of NK cells. Plays a pro-inflammatory role, in synergy with IL1B, by inducing NOS2 wich promotes the production of IL6, IL8 and Prostaglandin E2, through a signaling pathway that involves JAK2, PI3K, MAP2K1/MEK1 and MAPK14/p38. In adaptive immunity, promotes the switch of memory T-cells towards T helper-1 cell immune responses. Increases CD4(+)CD25(-) T-cell proliferation and reduces autophagy during TCR (T-cell receptor) stimulation, through MTOR signaling pathway activation and BCL2 up-regulation. . FUNCTION: Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways . In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, increases basal metabolism, influences reproductive function, regulates pancreatic beta-cell function and insulin secretion, is pro-angiogenic for endothelial cell and affects innate and adaptive immunity (By similarity) . In the arcuate nucleus of the hypothalamus, activates by depolarization POMC neurons inducing FOS and SOCS3 expression to release anorexigenic peptides and inhibits by hyperpolarization NPY neurons inducing SOCS3 with a consequent reduction on release of orexigenic peptides (By similarity). In addition to its known satiety inducing effect, has a modulatory role in nutrient absorption. In the intestine, reduces glucose absorption by enterocytes by activating PKC and leading to a sequential activation of p38, PI3K and ERK signaling pathways which exerts an inhibitory effect on glucose absorption . Acts as a growth factor on certain tissues, through the activation of different signaling pathways increases expression of genes involved in cell cycle regulation such as CCND1, via JAK2-STAT3 pathway, or VEGFA, via MAPK1/3 and PI3K-AKT1 pathways (By similarity) . May also play an apoptotic role via JAK2-STAT3 pathway and up-regulation of BIRC5 expression . Pro-angiogenic, has mitogenic activity on vascular endothelial cells and plays a role in matrix remodeling by regulating the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) . In innate immunity, modulates the activity and function of neutrophils by increasing chemotaxis and the secretion of oxygen radicals. Increases phagocytosis by macrophages and enhances secretion of pro-inflammatory mediators. Increases cytotoxic ability of NK cells . Plays a pro-inflammatory role, in synergy with IL1B, by inducing NOS2 wich promotes the production of IL6, IL8 and Prostaglandin E2, through a signaling pathway that involves JAK2, PI3K, MAP2K1/MEK1 and MAPK14/p38 . In adaptive immunity, promotes the switch of memory T-cells towards T helper-1 cell immune responses (By similarity). Increases CD4(+)CD25(-) T-cell proliferation and reduces autophagy during TCR (T-cell receptor) stimulation, through MTOR signaling pathway activation and BCL2 up-regulation . . FUNCTION: Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways. In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, increases basal metabolism, influences reproductive function, regulates pancreatic beta-cell function and insulin secretion, is pro-angiogenic for endothelial cell and affects innate and adaptive immunity. In the arcuate nucleus of the hypothalamus, activates by depolarization POMC neurons inducing FOS and SOCS3 expression to release anorexigenic peptides and inhibits by hyperpolarization NPY neurons inducing SOCS3 with a consequent reduction on release of orexigenic peptides. In addition to its known satiety inducing effect, has a modulatory role in nutrient absorption. In the intestine, reduces glucose absorption by enterocytes by activating PKC and leading to a sequential activation of p38, PI3K and ERK signaling pathways which exerts an inhibitory effect on glucose absorption. Acts as a growth factor on certain tissues, through the activation of different signaling pathways increases expression of genes involved in cell cycle regulation such as CCND1, via JAK2-STAT3 pathway, or VEGFA, via MAPK1/3 and PI3K-AKT1 pathways. May also play an apoptotic role via JAK2-STAT3 pathway and up-regulation of BIRC5 expression. Pro-angiogenic, has mitogenic activity on vascular endothelial cells and plays a role in matrix remodeling by regulating the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). In innate immunity, modulates the activity and function of neutrophils by increasing chemotaxis and the secretion of oxygen radicals. Increases phagocytosis by macrophages and enhances secretion of pro-inflammatory mediators. Increases cytotoxic ability of NK cells. Plays a pro-inflammatory role, in synergy with IL1B, by inducing NOS2 wich promotes the production of IL6, IL8 and Prostaglandin E2, through a signaling pathway that involves JAK2, PI3K, MAP2K1/MEK1 and MAPK14/p38. In adaptive immunity, promotes the switch of memory T-cells towards T helper-1 cell immune responses. Increases CD4(+)CD25(-) T-cell proliferation and reduces autophagy during TCR (T-cell receptor) stimulation, through MTOR signaling pathway activation and BCL2 up-regulation. . |
Accessions | ENST00000308868.5 D3HIE0 A4D0Y8 Q6NT58 P41159 |